Draft guidance the US Food and Drug Administration issued 25 October outlines how and why pharmaceutical companies should prepare to accept requests to host remote interactive evaluations at their manufacturing facilities.
Such evaluations by the FDA and other regulatory agencies, which can include screensharing and video walk-throughs, became popular during the...